Just out: "Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue (SMART)" Macromolecule protein fraction of SMART correlates with clinical tests, and inflammatory demyelination in a biopsied MS lesion. dx.doi.org/10.1002/acn3.5162…
1
Fond Farewell Feast for MS Fellow, Dr Victoria Levasseur. She is graduating, and headed to Minnesota to join a private practice group where she will focus on MS.
4
26
Anne H. Cross retweeted
Wonderful and inspiring talk at Washington University in St. Louis by @peter_agre about Aquaporins!! Your humanity goes beyond all the spectacular and so important discoveries!! Thank you 😊 – at St Louis, MO
Anne H. Cross retweeted
Our most recent #NeuroNights at Tower Grove Park was a success! The family picnic came with yard games and delicious barbecue from @PappySmokehouse! The weather was beautiful, and the company couldn't be beat. Thank you to Michelle Rudman for organizing and Kristin Guilliams!
Congratulations Biao Xiang! You worked hard to complete your post-doctoral project, & it was published online yesterday "Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue (SMART MRI)" Ann Clin Transl Neur
doi: 10.1002/acn3.51621
Anne H. Cross retweeted
The galaxy recently lost a star—actor, performer, and trailblazing #StarTrek icon, Nichelle Nichols.
In honor of her passing, @WUSTLlibraries has published the rarely seen interview she gave for documentarian William Miles's film 'Black Stars in Orbit.' https://teapaw.org/t.co/QP0V90M8Fc
Anne H. Cross retweeted
What a great day. Held our official ribbon cutting to open our new offices including the beautiful Dacey Auditorium. Packed house celebrating our new digs and our incredible staff who make everything possible.
#Makingadifference
@WashUNeurosurg
So happy to have renowned MS scientist and neuropathologist, Dr. Roberta Magliozzi, visiting our institution from Verona, IT
11
Anne H. Cross retweeted
Incredibly proud that @WashUNeurosurg residency has risen to #6 in the recent Doximity rankings. Congrats to our program director @JOsbunMDxCV, our program administrator Kayla Zoschg, our faculty, and all of our residents who make this possible.
Anne H. Cross retweeted
On the program at #IVBM2022:
Jonathan Kipnis @jonykipnis, Professor at Washington University School of Medicine in St. Louis, will present:
“Unexpected vascular findings at the brain borders”
Check out their lab website kipnislab.wustl.edu
Details & registration:
Anne H. Cross retweeted
Just spoke at the 4th ASNI course. Great audience of smart and thoughtful neuroimmunologists. !! Looking forward to talks by my esteemed colleagues, @DeSilvaTara and @RhondaVoskuhl ! Session sponsored by @ACTRIMS
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab is now published online and available in
Neurology and Therapy DOI 10.1007/s40120-022-00341-z
@SpringerNature @AnneHCross1
This short conference looks intriguing
Join 1300+ at this 14 credit virtual CME conference on post-COVID-19 neuropsychiatric sequelae, PANS/PANDAS, encephalitis, OCD. Speakers: Mayo, UCSF, Harvard, Duke, NIH, Stanford, Georgetown, Baylor, Oxford. Free to MDs/DOs/PhDs until 4/1. #neuroimmunology neuroimmune.org/inflammatory…
Anne H. Cross retweeted
#postdoc #opportunity if you love #Tcells #TCRs in the context of #human #neurological and #pediatric #diseases #DM or #email me. #Graduatestudents and #MSTPstudents welcome @WUSTL saligramalab.org
Anne H. Cross retweeted
Thank you to all the medical students and residents who attended the @ACTRIMS Neurology Resident Summit. We appreciated your feedback and kind remarks! @OhioStateNeuro @OSUNeuroInst
Sensational #talk by our own Claudia Cantoni at #ACTRIMS FORUM 2022! Lots of questions from audience.#MS #beyond_OCBs #singlecellRNACSF
@Clodida @LauraPiccio @AnneHCross1 @MS_ResearchDoc @BrianEdelson2
Anne H. Cross retweeted
This is a small study but motivates the use of this technique, and techniques like it, for the study of ongoing progressive symptom accumulation in progressive MS. The hope is that with a better biomarker we can better assess potential therapies.






















